Treatment of the genetic defect of cholesterol biosynthetic pathway.
Phase 2
Completed
- Conditions
- CHILD syndrome, Conradi syndrome, porokeratosis, atopic dermatitis, psoriasis, seborrheic dermatitisDermatitis and eczema
- Registration Number
- JPRN-jRCTs031180409
- Lead Sponsor
- Kubo Akiharu
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 158
Inclusion Criteria
Patients of CHILD syndrome or Conradi syndrome confirmed by genetic diagnosis.
Patients of atopic dermatitis, psoriasis vulgaris, seborrheic dermatitis, and porokeratosis diagnosed clinically.
Healthy subject.
Exclusion Criteria
Patients without skin manifestations.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement of skin erythema and scales
- Secondary Outcome Measures
Name Time Method Rate of common adverse events